OVERVIEW
This course will review the latest treatment modalities
in uveitis including the intravitreal delivery systems for
long acting and short acting steroids and the various
anti-tumor necrosis factor alpha agents. We will compare
these new treatments to the currently accepted systemic
immunosuppression regimens with steroids and non-
steroidal immunosuppressive therapy. Updates on infectious
uveitis syndromes will be presented. Case presentations
with emphasis on audience interaction will provide
insight on how to conduct a uveitis work up and how
to treat various syndromes.
KEY DATES
20 Apr, 2013
Event Start Date
20 Apr, 2013
Event End Date
SPECIALITIES
OphthalmologySUGGESTED HOTELS
CONFERENCE VENUE
Cole Eye Institute James P. Storer Conference Center, 1st Floor, 2022 E 105th St